Found: 12
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 1, doi. 10.1111/1440-1681.13655
- Publication type:
- Article
Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 3, doi. 10.1111/1440-1681.13725
- By:
- Publication type:
- Article
Angiotensin‐receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT‐5A pathway.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 19, doi. 10.1111/1440-1681.13715
- By:
- Publication type:
- Article
Molecular insight of p53/Sp1/MUC5AC axis in the tumorigenesis and progression of lung adenocarcinoma.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 28, doi. 10.1111/1440-1681.13720
- By:
- Publication type:
- Article
A gain of function ryanodine receptor 2 mutation (R1760W‐RyR2) in catecholaminergic polymorphic ventricular tachycardia.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 39, doi. 10.1111/1440-1681.13722
- By:
- Publication type:
- Article
SIRT1 targeted by miR‐211‐5p regulated proliferation and apoptosis of Dex‐treated growth plate chondrocytes via mediating SOX2.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 50, doi. 10.1111/1440-1681.13721
- By:
- Publication type:
- Article
Fibroblast growth factor 10 ameliorates renal ischaemia–reperfusion injury by attenuating mitochondrial damage.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 59, doi. 10.1111/1440-1681.13724
- By:
- Publication type:
- Article
Dapagliflozin modulates the faecal microbiota after myocardial infarction in non‐diabetic mice.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 68, doi. 10.1111/1440-1681.13727
- By:
- Publication type:
- Article
Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII‐induced angiogenesis by interacting with IRE1 in its active conformation.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 82, doi. 10.1111/1440-1681.13726
- By:
- Publication type:
- Article
Nicorandil mitigates amiodarone‐induced pulmonary toxicity and fibrosis in association with the inhibition of lung TGF‐β1/PI3K/Akt1‐p/mTOR axis in rats.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 96, doi. 10.1111/1440-1681.13728
- By:
- Publication type:
- Article
Ulinastatin affects focal cerebral ischemia–reperfusion injury via SOCS1‐mediated JAK2/STAT3 signalling pathway.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 1, p. 107, doi. 10.1111/1440-1681.13731
- By:
- Publication type:
- Article
Erratum to "A novel synthetised sulphonylhydrazone coumarin (E)‐4‐methyl‐N0 ‐(1‐(3‐oxo‐3H‐benzo[f]chromen‐2‐ yl) ethylidene)benzenesulphonohydrazide protect against isoproterenol‐induced myocardial infarction in rats by attenuating oxidative damage, biological changes and electrocardiogram"
- Published in:
- 2023
- Publication type:
- Correction Notice